Piramal Pharma Limited will be hosting a conference call for investors / analysts on 29th January 2025 from 5:30 PM to 6:15 ...

Piramal Pharma is approaching the next few months with “cautious optimism”, given the geopolitical uncertainty and directives from the new administration in the United States. Customers ...

Several top brokerage firms have expressed their positive views on the Piramal Pharma stock in the recent past. In January's first week, global brokerage firm Jefferies raised its target price for ...

As of late morning trading, the shares were up 7.7 per cent at Rs 238.55 apiece. Piramal Pharma had previously declined 12 per cent over the last three sessions and is down 10 per cent so far in ...

Stock Market Today: Piramal Pharma share price gained more than 8% in intraday trades on Wednesday. Piramal Pharma share ...

Piramal Pharma was demerged from PEL in August, as part of the strategy to simplify the company's corporate structure. Advisory Alert: It has come to our attention that certain individuals are ...

Piramal Pharma share price opened at ₹ 217.85 against its previous close of ₹ 221.65 and jumped 9.45 per cent to the level of ₹ 242.60. Around 11:50 AM, the stock traded 6.07 per cent up at ...

Piramal Pharma Limited said, "FY25 so far has been a steady year for the Company with revenue growth of 14% and EBITDA growing at 20%. Our CDMO business continues to deliver robust performance ...

Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17 * global development and manufacturing facilities and a global ...